The global premenstrual syndrome treatment market was valued at $1129 million in 2018, and is projected to reach $1516 million by 2026, registering a CAGR of 3.7% from 2019 to 2026 - P&T Community
Submitted by Anonymous (not verified) on Mon, 03/09/2020 - 20:05
